MAP Pharmaceuticals, Inc. (MAPP) Posts Wider than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts MAPP Hot Sheet
Price: $28.11 --0%
Financial Fact:
Research and development: 7.86M
Today's EPS Names:
YRD, CAG, CALM, More
Financial Fact:
Research and development: 7.86M
Today's EPS Names:
YRD, CAG, CALM, More
Join SI Premium – FREE
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q1 EPS of ($0.58), $0.19 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.1 million.
For earnings history and earnings-related data on MAP Pharmaceuticals, Inc. (MAPP) click here.
For earnings history and earnings-related data on MAP Pharmaceuticals, Inc. (MAPP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Carriage Services ends $100M equity program, cuts leverage target
- Airbnb adds social features and AI tools to trip planning
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
